ABUS is a turnaround opportunity insofar as the investment community has written them off as a failure in HBV (e.g. #msg-144116381), but this program may be in better shape than investors think.
I don’t own the stock, but I picked it in the SI charity contest.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.